Company: SHPH
Filing Date: 2025-03-19
Form Type: PRE 14A
Source: 0001493152-25-010886
Chunk: 34

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-19
Form: PRE 14A
Chunk 34
---
’s adjusted tax basis in the shares of common stock surrendered that is allocable to such fractional share. Such capital gain or loss generally should be long-term capital gain or loss if the U.S. Holder’s holding period for the shares of common stock surrendered exceeded one year at the effective time of the Reverse Stock Split. Stockholders should consult their tax advisors regarding the tax effects to them of receiving cash in lieu of fractional shares based on their particular circumstances.

A U.S. Holder may be subject to information reporting with respect to any cash received in lieu of a fractional share in the Reverse Stock Split. U.S. Holders who are subject to information reporting and who do not provide a correct taxpayer identification number and other required information (such as by submitting a properly completed Internal Revenue Service Form W-9) may also be subject to backup withholding at the applicable rate. Any amount withheld under such rules is not an additional tax and may be refunded or credited against the U.S. Holder’s U.S. federal income tax liability, provided that the required information is properly furnished in a timely manner to the Internal Revenue Service. Stockholders should consult their tax advisors regarding their qualification for an exemption from backup withholding and the procedures for obtaining such an exemption.

| 26 |

Questions and Answers About the Meeting

Why am I receiving these materials?

You are receiving these materials because you were astockholder of Shuttle Pharmaceuticals Holdings, Inc. (the “Company”) as of March 13, 2025, which is the Record Date of our 2025 Annual Meeting of Stockholders. Our 2025 Annual Meeting of Stockholders will be held virtually on Friday, May 9, 2025 at www.virtualshareholdermeeting.com/SHPH2025.

What proposals will be voted on at the Annual Meeting and how does the Board of Directors recommend that i vote?

| PROPOSAL                                                                                                                           
 1: ELECTION OF DIRECTORS                                                                                                           |
| The                                                                                                                                
 Board of Directors recommends that you vote FOR each director nominee. These individuals bring a range of relevant experiences and 
 overall diversity of perspectives that is essential to good governance and leadership of our Company.                              |

| PROPOSAL                                                                                                                     
 3: EXECUTIVE COMPENSATION                                                                                                    |
| The                                                                                                                          
 Board of Directors recommends that you vote FOR approval of the Company’s executive compensation plan, on an advisory basis. 
 We believe the numbers that we have prepared are fair and in the best interest of the Company’s executives and stockholders. |

PROPOSAL NO.